Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3048821	pt-dxm-r1	— (—)	4483	5823	100.00%	Distribution not available
3048821	pt-dxm-r1	nmol/l (nmol/l)	38	38	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of other endocrine glands

783

1663

4.76

307.65

1.4

1.3

29.00

30.67

nmol/l

—

Obesity

1014

2546

4.04

307.65

1.2

1.3

27.00

29.27

nmol/l

0.13

Other nutritional deficiencies

1052

2606

4.04

307.65

1.2

1.3

27.00

28.83

nmol/l

0.10

Obesity and other hyperalimentation

1016

2557

4.03

307.65

1.2

1.3

27.00

29.27

nmol/l

0.13

Hypertension, essential

1068

1582

3.92

295.93

1.3

34.43

25.08

nmol/l

—

Endocrine, nutritional and metabolic diseases

1014

1245

4.20

292.46

1.3

28.21

30.14

nmol/l

0.11

Obesity due to excess calories

769

1849

4.27

287.03

1.2

1.3

21.38

31.22

nmol/l

—

Hypertensive diseases (excluding secondary)

821

1074

4.53

272.94

1.3

25.71

27.71

nmol/l

—

Hypertension

1039

1619

3.69

265.27

1.3

25.71

24.43

nmol/l

—

Hypertensive diseases

1038

1620

3.68

264.55

1.3

25.71

24.43

nmol/l

—

Exclusions for E4_PCOS_BROAD

411

613

7.03

263.16

1.7

1.3

29.60

36.38

nmol/l

—

Benign neoplasms

1088

2123

2.89

191.70

1.4

1.2

32.20

25.95

nmol/l

—

Sleep apnoea

1089

2745

2.73

182.75

1.3

27.22

29.78

nmol/l

—

Sleep apnoea, including avohilmo

1136

2794

2.67

181.28

1.3

27.22

29.78

nmol/l

—

Sleep disorders (combined)

1156

2908

2.64

180.49

1.3

32.80

26.95

nmol/l

—

Type 2 diabetes

1148

2607

2.65

175.30

1.3

23.55

33.69

nmol/l

0.77

Type 2 diabetes, wide definition

916

2069

2.92

172.51

1.3

29.20

33.71

nmol/l

—

Diabetes mellitus

1173

2762

2.56

168.73

1.3

23.55

32.09

nmol/l

0.72

Benign neoplasms

883

1681

3.01

166.86

1.4

1.3

32.20

26.00

nmol/l

—

Diabetes, varying definitions

1163

2764

2.54

164.71

1.3

23.55

32.09

nmol/l

0.72

Type 2 diabetes, strict (exclude DM1)

1071

2494

2.59

157.73

1.3

21.63

33.69

nmol/l

—

Type 2 diabetes, definitions combined

1065

2479

2.59

156.83

1.3

21.63

33.69

nmol/l

—

Type 2 diabetes, definitions combined, including avohilmo

1069

2484

2.58

155.09

1.3

21.63

33.69

nmol/l

—

Cardiovascular diseases (excluding rheumatic etc)

757

1427

3.10

151.53

1.3

29.86

24.86

nmol/l

—

Antihypertensive medication - note that there are other indications

701

1182

3.28

150.51

1.3

27.75

27.46

nmol/l

0.01

Other (not insulin) diabetes medications

1072

2617

2.50

146.88

1.3

22.00

33.69

nmol/l

—

Osteopathies and chondropathies

670

2147

3.01

146.36

1.3

51.40

30.59

nmol/l

—

Diabetes medication

1134

2876

2.42

146.18

1.3

23.55

32.09

nmol/l

0.72

Metabolic disorders

1029

2584

2.50

142.71

1.4

1.3

25.17

30.95

nmol/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1032

2550

2.50

142.14

1.3

27.86

32.53

nmol/l

—

Episodal and paroxysmal disorders

1161

2577

2.33

131.18

1.3

27.75

30.72

nmol/l

0.17

Biguanides

1013

2615

2.41

130.12

1.3

23.88

34.00

nmol/l

—

Diabetes, insulin treatment (Kela reimbursement)

1055

2805

2.32

124.66

1.3

27.86

29.38

nmol/l

—

Depression medications

323

297

5.54

124.25

1.4

1.3

30.00

26.40

nmol/l

—

Neoplasms

751

1518

2.67

114.11

1.4

1.2

32.11

28.09

nmol/l

—

Cardiovascular diseases

659

1275

2.84

112.35

1.3

26.29

29.28

nmol/l

—

Abnormalities of breathing

935

2423

2.31

108.84

1.4

1.3

27.89

30.33

nmol/l

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

445

1426

3.18

108.36

1.5

1.3

24.00

30.08

nmol/l

—

Medical observation and evaluation for suspected diseases and conditions

734

1461

2.60

103.95

1.4

1.3

29.70

22.00

nmol/l

—

Any gastric operation

790

1606

2.49

102.24

1.4

1.3

25.44

30.47

nmol/l

—

GASTRO-related operations

790

1606

2.49

102.24

1.4

1.3

25.44

30.47

nmol/l

—

Other disorders of fluid, electrolyte and acid-base balance

341

943

3.55

98.26

1.4

1.3

—

35.88

—

Other antidepressants

1014

2467

2.16

97.26

1.3

29.10

32.55

nmol/l

—

Codeine

953

2412

2.19

95.65

1.3

25.22

30.50

nmol/l

—

Neurological diseases

865

1908

2.30

94.98

1.4

1.3

27.29

30.32

nmol/l

—

General symptoms and signs

1080

2623

2.08

92.96

1.4

1.3

27.00

30.11

nmol/l

0.18

Malaise and fatigue

500

1527

2.76

91.37

1.4

1.3

33.83

35.17

nmol/l

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1065

2999

2.04

90.41

1.3

33.70

29.24

nmol/l

—

Persons encountering health services in other circumstances, wide

1151

3008

2.00

90.36

1.3

26.44

29.24

nmol/l

—

Depression or dysthymia

710

1655

2.42

89.98

1.3

36.30

28.58

nmol/l

—

Mood disorders, excluding more controls

940

2723

2.12

89.40

1.3

38.18

25.06

nmol/l

0.79

Opioids

969

2448

2.09

86.17

1.3

29.80

30.50

nmol/l

—

Obesity related asthma

399

1407

2.88

82.11

1.3

21.17

35.92

nmol/l

—

Recurrent or chronic depression

447

1158

2.82

82.02

1.3

18.17

28.58

nmol/l

—

Mood disorders

1002

3345

1.98

81.52

1.3

38.18

26.04

nmol/l

0.72

Mood [affective] disorders

1000

3344

1.98

81.32

1.3

38.18

26.04

nmol/l

0.72

Codeine or tramadol medication

1097

3147

1.94

81.11

1.3

25.22

31.12

nmol/l

—

Other soft tissue disorders, not elsewhere classified

879

2642

2.07

79.39

1.3

29.71

28.42

nmol/l

—

Parasetamol

752

1723

2.24

78.57

1.4

1.3

28.70

30.19

nmol/l

—

Low back pain

707

2496

2.20

78.29

1.4

1.3

50.00

22.81

nmol/l

—

Disorders of the thyroid gland

910

2974

2.02

77.44

1.3

32.50

28.71

nmol/l

—

Depression

931

3268

1.98

75.95

1.3

25.75

26.04

nmol/l

—

Symptoms and signs involving the circulatory and respiratory systems

956

2430

1.99

73.12

1.3

24.44

30.33

nmol/l

—

Dorsalgia

934

2573

1.98

72.34

1.4

1.3

43.50

22.95

nmol/l

—

Cardiac arrhythmias

575

1625

2.36

72.28

1.3

22.86

33.00

nmol/l

—

Diseases of oesophagus, stomach and duodenum

995

3177

1.92

72.21

1.3

25.88

30.48

nmol/l

—

Used for control exclusion in common control thyroid runs

948

2463

1.96

70.60

1.4

1.3

25.92

32.37

nmol/l

0.55

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

31.79

69.53

1.2

1.6

—

Lower back pain or/and sciatica

949

3497

1.90

68.77

1.4

1.3

42.86

25.37

nmol/l

—

Anxiety disorders, excluding more controls

786

2587

2.03

68.56

1.4

1.3

23.33

25.06

nmol/l

0.14

Exclusions for E4_PCOS_CONSORTIUM

757

2316

2.07

68.28

1.5

1.3

33.15

26.40

nmol/l

0.44

Anxiety (asthma-related co-morbidities)

598

2148

2.21

67.74

1.3

22.88

26.86

nmol/l

—

Asthma, excluding more controls

717

1809

2.13

66.96

1.3

25.33

42.50

nmol/l

—

Benzodiazepine use

917

3472

1.89

66.51

1.3

21.60

30.24

nmol/l

—

Abdominal and pelvic pain

904

2345

1.95

65.95

1.4

1.3

21.13

28.91

nmol/l

—

Hypothyroidism, other/unspecified

829

2814

1.96

65.48

1.3

33.38

28.87

nmol/l

—

Headache

611

2396

2.15

65.08

1.3

33.80

30.11

nmol/l

—

Asthma

730

1895

2.08

64.57

1.3

25.33

42.18

nmol/l

—

Selective serotonin reuptake inhibitors

897

2468

1.93

63.90

1.3

24.92

32.55

nmol/l

0.54

Dyspnoea

797

3164

1.94

63.53

1.3

25.57

31.43

nmol/l

—

Insulin medication

506

1908

2.29

63.06

1.4

1.3

32.60

33.67

nmol/l

—

Asthma (mode)

719

1924

2.07

62.92

1.3

26.00

42.18

nmol/l

—

Symptoms and signs involving the digestive system and abdomen

895

2345

1.92

62.84

1.3

23.13

28.91

nmol/l

—

General examination and investigation of persons without complaint and reported diagnosis

602

1461

2.21

61.62

1.3

27.20

22.00

nmol/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

856

3009

1.89

61.00

1.3

33.38

28.25

nmol/l

—

Any mental disorder

1003

2759

1.83

60.68

1.4

1.3

35.27

25.06

nmol/l

0.82

All anxiety disorders

605

2359

2.08

58.97

1.3

22.88

31.04

nmol/l

—

Psychiatric diseases

982

2714

1.82

58.58

1.4

1.3

35.00

25.79

nmol/l

0.66

Asthma, unspecified (mode), excluding more controls

476

1655

2.28

57.76

1.3

25.33

42.50

nmol/l

—

Neurotic, stress-related and somatoform disorders

830

3195

1.86

57.16

1.4

1.3

23.33

31.04

nmol/l

0.73

Other diseases of intestines

939

3031

1.81

57.01

1.4

1.3

31.91

28.19

nmol/l

0.22

Anxiety disorders

835

3217

1.85

56.77

1.4

1.3

23.33

31.04

nmol/l

0.73

Pain in joint

501

1514

2.21

54.33

1.3

19.71

26.36

nmol/l

—

Asthma, unspecified (mode)

478

1733

2.20

53.82

1.3

25.33

42.18

nmol/l

—

Spondylopathies

687

2144

1.96

53.48

1.4

1.3

38.00

24.00

nmol/l

—

Asthma (only as main-diagnosis), excluding more controls

614

1809

2.04

52.87

1.3

28.63

42.50

nmol/l

—

Any reimbursement code in KELA

526

1203

2.21

52.85

1.3

38.17

31.85

nmol/l

—

Other dorsopathies, not elsewhere classified

880

2577

1.81

52.31

1.4

1.3

40.38

22.95

nmol/l

—

Insulin, intermediate and long-acting

473

2177

2.15

52.12

1.4

1.3

32.60

28.35

nmol/l

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

837

3367

1.79

51.45

1.3

40.67

28.00

nmol/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

329

608

2.73

51.42

1.3

33.40

33.57

nmol/l

—

Hypothyroidism, strict autoimmune

643

2194

1.95

50.68

1.3

36.50

31.44

nmol/l

—

Asthma (only as main-diagnosis)

618

1895

1.98

49.57

1.3

28.63

42.18

nmol/l

—

Dorsopathies

894

2584

1.78

49.38

1.4

1.3

39.73

23.25

nmol/l

1.38

First line medication for Crohn's disease

959

3072

1.71

47.51

1.4

1.3

26.64

30.45

nmol/l

0.23

Diseases of the musculoskeletal system and connective tissue

471

1083

2.20

46.96

1.3

37.00

22.38

nmol/l

—

Pain (limb, back, neck, head abdominally)

610

1552

1.98

46.72

1.4

1.3

29.71

26.36

nmol/l

—

Chronic lower respiratory diseases

1034

3370

1.67

46.53

1.3

25.55

31.19

nmol/l

0.48

Hypertensive Heart Disease

167

391

3.53

46.28

1.5

1.3

—

ILD medications: prednisolone, methylprednisolone, prednisone

942

3151

1.70

45.76

1.3

26.17

30.45

nmol/l

0.29

Insulin, combination of fast acting with intermediate-acting or long-acting

506

2348

2.00

45.70

1.4

1.3

32.60

27.67

nmol/l

—

Other headache syndromes

377

1721

2.21

44.84

1.4

1.3

28.40

33.31

nmol/l

—

Other anxiety disorders

427

1815

2.10

43.84

1.3

25.80

30.19

nmol/l

—

Other pulmonary diagnosis

700

1915

1.84

43.37

1.4

1.3

22.86

42.18

nmol/l

—

Gastrointestinal diseases

525

1301

2.03

43.28

1.3

28.29

32.20

nmol/l

—

Oral corticosteroids

901

3253

1.68

43.20

1.3

27.82

30.45

nmol/l

0.15

Excluding asthma or asthma-COPD overlap

692

1915

1.82

41.38

1.3

22.86

42.18

nmol/l

—

Other heart diseases, wide

798

2906

1.71

40.91

1.3

27.38

27.58

nmol/l

—

Inflammatory bowel disease treatment related agents

960

3360

1.63

40.19

1.3

26.29

30.45

nmol/l

0.31

Asthma (diagnoses ohter than nonallergic)

718

3595

1.72

39.52

1.3

27.33

30.24

nmol/l

—

ILD differential diagnosis

686

1924

1.80

39.31

1.3

22.86

42.18

nmol/l

—

COPD differential diagnosis

685

1925

1.79

39.02

1.3

22.86

42.18

nmol/l

—

Asthma, including avohilmo

969

3508

1.61

38.99

1.3

28.46

30.12

nmol/l

0.10

Soft tissue disorders

855

2671

1.67

38.51

1.3

29.92

28.95

nmol/l

0.06

Finngen Rheumatological endpoints

822

2809

1.68

38.34

1.3

35.64

23.70

nmol/l

0.88

ILD medications

940

3204

1.62

37.89

1.3

26.64

30.45

nmol/l

0.23

Examination and observation for other reasons

470

1454

1.98

37.84

1.3

19.80

22.00

nmol/l

—

COPD/asthma related infections

892

2728

1.65

37.59

1.3

18.50

35.22

nmol/l

2.24

COPD/asthma/ILD related infections

892

2728

1.65

37.59

1.3

18.50

35.22

nmol/l

2.24

Hypothyroidism, strict autoimmune, 3 medication purchases required

701

2828

1.70

35.75

1.3

38.60

28.74

nmol/l

—

Asthma-related infections

467

2480

1.86

34.76

1.3

25.00

33.43

nmol/l

—

Asthma, hospital admission 2, infections

467

2480

1.86

34.76

1.3

25.00

33.43

nmol/l

—

Dental pulpitis 1, only avohilmo

898

2945

1.60

34.24

1.3

28.89

29.89

nmol/l

—

Autoimmune diseases

899

2885

1.60

34.03

1.3

26.67

30.50

nmol/l

0.30

Dental pulpitis 1

874

2840

1.61

33.87

1.3

28.89

29.89

nmol/l

—

Dental pulpitis 4

874

2840

1.61

33.84

1.3

28.89

29.89

nmol/l

—

Diseases of pulp and periapical tissues, including avohilmo

872

2834

1.61

33.75

1.3

28.89

29.89

nmol/l

—

Other specific joint derangements/joint disorders

605

2342

1.74

33.59

1.3

19.71

31.20

nmol/l

—

923

3100

1.58

33.50

1.3

21.56

32.43

nmol/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

530

1461

1.84

33.37

1.3

19.83

22.00

nmol/l

—

Pain, not elsewhere classified

237

1013

2.36

33.18

1.4

1.2

24.33

32.33

nmol/l

—

Dental pulpitis 4, only avohilmo

891

2941

1.59

33.08

1.3

28.89

29.89

nmol/l

—

Complications of surgical and medical care, not elsewhere classified

780

3481

1.61

33.03

1.3

31.33

29.68

nmol/l

—

Nausea and vomiting

217

881

2.45

32.71

1.3

—

37.00

—

Malignant neoplasm of adrenal gland

69.30

32.24

1.3

1.7

—

714

2724

1.65

32.16

1.4

1.3

19.00

35.22

nmol/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

714

2724

1.65

32.16

1.4

1.3

19.00

35.22

nmol/l

—

Complications of procedures, not elsewhere classified

645

3363

1.67

31.93

1.4

1.3

31.13

29.09

nmol/l

—

367

1871

1.96

31.87

1.3

25.00

34.70

nmol/l

—

Fall on same level

937

3392

1.55

31.79

1.3

35.83

28.38

nmol/l

—

Other and unspecified anaemias

302

1420

2.07

30.58

1.3

—

33.73

—

Genitourinary diseases

471

1280

1.85

30.12

1.3

36.88

25.38

nmol/l

—

Other anaemias

303

1437

2.05

29.76

1.3

—

33.73

—

Diseases of the skin and subcutaneous tissue

829

2671

1.56

28.58

1.3

24.73

33.06

nmol/l

0.69

Acute upper respiratory infections

820

3332

1.55

28.45

1.3

18.50

34.26

nmol/l

—

Aplastic and other anaemias

318

1546

1.96

27.68

1.3

—

31.64

—

Autoimmune diseases related-to ILD

666

3699

1.59

27.59

1.3

27.89

28.77

nmol/l

—

Acute upper respiratory infections of multiple and unspecified sites

589

2689

1.65

27.49

1.3

22.50

34.05

nmol/l

—

Other arrhythmias

508

2283

1.71

27.44

1.3

18.20

31.61

nmol/l

—

Certain infectious and parasitic diseases

821

2668

1.55

27.13

1.4

1.3

31.75

29.61

nmol/l

0.12

Bronchitis

830

3585

1.52

27.12

1.3

21.56

30.81

nmol/l

—

Falls/tendency to fall

893

2961

1.52

26.92

1.3

27.50

29.00

nmol/l

—

Irritable bowel syndrome

244

1159

2.13

26.55

1.4

1.3

22.33

28.27

nmol/l

—

Diseases of the respiratory system

526

1542

1.72

26.23

1.4

1.3

31.57

37.43

nmol/l

—

Fever of other and unknown origin

385

1980

1.81

26.15

1.3

30.88

31.69

nmol/l

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

742

3387

1.54

25.89

1.3

21.43

32.65

nmol/l

—

Other joint disorders

702

2376

1.58

25.80

1.3

28.82

31.20

nmol/l

0.13

Persons encountering health services for examination and investigation

501

1461

1.73

25.52

1.3

36.13

22.00

nmol/l

—

Dizziness and giddiness

565

2843

1.62

25.04

1.4

1.3

22.80

34.25

nmol/l

—

External causes of morbidity and mortality

553

1669

1.67

24.83

1.3

29.83

25.29

nmol/l

—

Hyperhidrosis

5.27

24.44

1.6

1.3

—

Injuries to the knee and lower leg

909

3567

1.46

23.88

1.3

29.50

29.57

nmol/l

—

Asthma, hospital admissions , main diagnosis only

631

3649

1.56

23.87

1.3

28.63

29.80

nmol/l

—

Cystitis

667

2629

1.56

23.79

1.4

1.3

38.50

30.55

nmol/l

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

327

3.06

22.77

1.3

—

37.00

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

727

3293

1.51

22.74

1.3

31.00

29.90

nmol/l

—

Autoimmune diseases excluding thyroid diseases

770

2866

1.50

22.47

1.3

23.13

30.50

nmol/l

—

Shoulder lesions

571

2209

1.59

22.28

1.3

31.33

31.82

nmol/l

—

Pneumonias (Asthma/COPD co-morbidities)

758

3548

1.49

22.27

1.4

1.3

19.00

33.25

nmol/l

—

All pneumoniae

759

3555

1.48

21.81

1.4

1.3

19.00

33.25

nmol/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

394

2283

1.70

21.66

1.4

1.3

26.00

29.15

nmol/l

—

Influenza and pneumonia

796

3588

1.46

21.55

1.4

1.3

19.00

33.32

nmol/l

—

Cough

295

1542

1.85

21.53

1.3

36.17

35.27

nmol/l

—

Infections of the skin and subcutaneous tissue

426

2579

1.65

21.18

1.4

1.3

27.50

26.88

nmol/l

—

Pneumonia, organism unspecified

675

3265

1.50

21.06

1.4

1.3

20.43

34.45

nmol/l

—

Injury, poisoning and certain other consequences of external causes

445

1327

1.69

21.03

1.3

37.43

21.22

nmol/l

—

Other diseases of urinary system

773

2969

1.47

20.78

1.3

35.50

28.74

nmol/l

—

Asthma/COPD (KELA code 203)

705

3359

1.48

20.77

1.3

28.14

31.19

nmol/l

—

Adrenomedullary hyperfunction

40.69

20.41

1.2

1.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

731

3514

1.47

20.28

1.4

1.3

19.63

33.54

nmol/l

—

Gingivitis and periodontal diseases

675

2335

1.50

19.58

1.3

26.90

34.17

nmol/l

—

Autoimmune diseases excluding thyroid diseases, strict definition

718

2724

1.47

19.55

1.3

23.12

30.50

nmol/l

—

Complications of medical and surgical care

529

3287

1.53

19.15

1.3

28.83

30.24

nmol/l

—

KRA_PSY_EATING, excluding more controls

241

3.18

19.14

1.2

—

30.67

—

Other acute lower respiratory infections

370

2129

1.67

18.95

1.3

40.20

28.33

nmol/l

—

Dental caries 3 and operation codes

650

2246

1.49

18.41

1.3

34.80

30.81

nmol/l

—

Diseases of the ear and mastoid process

902

3268

1.40

18.41

1.3

27.17

30.65

nmol/l

0.24

Other external causes of accidental injury

649

2192

1.49

18.19

1.4

1.3

28.50

28.86

nmol/l

—

Disorders of adrenal gland, other and/or unspecified

15.92

17.85

1.4

1.2

—

Dental caries 3, only avohilmo

591

2016

1.50

17.56

1.3

34.33

33.14

nmol/l

—

Accidents

644

2192

1.48

17.40

1.4

1.3

30.29

28.86

nmol/l

—

Disorders of synovium and tendon

383

2141

1.62

17.40

1.4

1.3

41.50

30.33

nmol/l

—

Diseases of oral cavity, salivary glands and jaws

665

2337

1.46

17.34

1.3

27.70

34.17

nmol/l

—

Dermatitis and eczema

793

3712

1.40

17.33

1.4

1.3

27.45

30.41

nmol/l

0.16

Gonarthrosis,primary

619

2654

1.47

17.27

1.2

1.3

—

32.44

—

Acute bronchitis

287

1633

1.73

17.06

1.3

40.20

30.45

nmol/l

—

Oxycodone

225

1178

1.86

16.92

1.3

—

29.10

—

Arthropathies

676

2377

1.45

16.86

1.3

28.00

31.20

nmol/l

0.19

Other diseases of upper respiratory tract

808

3011

1.40

16.83

1.3

31.91

27.33

nmol/l

0.25

Dental caries 3

578

1983

1.49

16.70

1.3

34.33

33.14

nmol/l

—

Disorders of eyelid, lacrimal system and orbit

600

3235

1.46

16.69

1.4

1.3

25.17

31.14

nmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

197

1033

1.92

16.46

1.3

35.00

25.00

nmol/l

—

Dental caries, including avohilmo

543

1848

1.51

16.33

1.3

36.25

31.42

nmol/l

—

Dental caries 1

543

1851

1.50

16.20

1.3

36.25

31.42

nmol/l

—

Mixed hyperlipidaemia

4.31

16.02

1.3

1.2

—

Polyarthropathies

472

2065

1.53

16.02

1.3

18.33

35.27

nmol/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

429

2789

1.54

15.97

1.3

28.83

32.65

nmol/l

—

Abnormal findings on diagnostic imaging of lung

303

1771

1.67

15.96

1.4

1.3

—

35.54

—

Artrosis, including avohilmo

621

2351

1.45

15.90

1.3

33.20

29.18

nmol/l

—

Dental caries 1, only avohilmo

547

1886

1.49

15.52

1.3

36.25

31.42

nmol/l

—

Erysipelas

360

2071

1.59

15.42

1.4

1.3

—

33.29

—

Hypermobility syndrome

211

3.04

14.71

1.5

1.3

—

37.00

—

Ventral hernia

177

932

1.91

14.70

1.3

—

31.87

—

Persons encountering health services for specific procedures and health care

777

3522

1.37

14.61

1.3

26.87

30.27

nmol/l

—

Injuries to the ankle and foot

496

3099

1.46

14.36

1.3

31.00

28.90

nmol/l

—

Exposure to unspecified factor

682

3829

1.39

14.29

1.2

1.3

34.80

28.76

nmol/l

—

Dental pulpitis 2, only avohilmo

484

1661

1.50

14.16

1.3

33.67

31.91

nmol/l

—

Dental caries 1 and operation codes

595

2136

1.43

14.01

1.3

40.33

29.00

nmol/l

—

Dental pulpitis 2

471

1617

1.50

13.81

1.3

33.67

31.91

nmol/l

—

Fracture of rib(s), sternum and thoracic spine

189

1041

1.83

13.65

1.3

—

35.00

—

Injuries to the thorax

289

1799

1.61

13.33

1.3

—

31.00

—

Hernia of abdominal wall

301

1910

1.58

12.85

1.3

—

29.12

—

Primary gonarthrosis, bilateral

328

1855

1.55

12.66

1.3

—

39.09

—

Pulmonary heart disease, diseases of pulmonary circulation

199

1144

1.75

12.47

1.4

1.3

—

31.91

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

387

2616

1.48

12.30

1.3

28.83

32.65

nmol/l

—

Other diseases of pleura

262

1437

1.62

12.20

1.3

—

34.67

—

Intestinal infectious diseases

646

3706

1.36

12.16

1.3

29.80

29.52

nmol/l

—

Brachial plexus disorders

367

2.34

12.03

1.5

1.2

—

32.60

—

Diseases of the eye and adnexa

609

2204

1.39

12.00

1.3

28.29

29.38

nmol/l

0.06

Polyuria

143

760

1.89

11.66

1.3

—

37.86

—

Hernia

644

3232

1.36

11.62

1.3

30.40

29.36

nmol/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

262

1647

1.60

11.61

1.3

31.50

27.33

nmol/l

—

Other and unspecified dermatitis

346

2318

1.50

11.57

1.3

35.20

34.38

nmol/l

—

Fenamates

105

338

2.11

10.74

1.2

—

Noninflammatory disorders of female genital tract

340

1135

1.51

10.61

1.3

29.00

31.00

nmol/l

—

102

500

2.06

10.57

1.2

1.3

—

43.00

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

620

2732

1.35

10.47

1.3

—

31.20

—

Malignant neoplasm, wide definition for exclusion

620

2732

1.35

10.47

1.3

—

31.20

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

620

2732

1.35

10.47

1.3

—

31.20

—

Any event in cancer register

657

2934

1.33

10.38

1.3

—

30.90

—

Dermatitis

401

2828

1.42

10.31

1.4

1.3

35.20

31.81

nmol/l

—

Disorders of conjunctiva

564

3511

1.35

10.26

1.3

29.56

29.55

nmol/l

—

Cardiodefibrillation

208

1280

1.63

10.15

1.3

—

38.71

—

Problems related to lifestyle

344

2.26

10.12

1.3

—

43.00

—

Pulmonary embolism

177

1051

1.69

9.99

1.4

1.3

—

31.91

—

Pulmonary heart disease

177

1054

1.69

9.88

1.4

1.3

—

31.91

—

Triptan medication for migraine, single purchase ok

570

2900

1.33

9.40

1.4

1.3

40.80

26.35

nmol/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

570

2900

1.33

9.40

1.4

1.3

40.80

26.35

nmol/l

—

Hard cardiovascular diseases

509

2411

1.36

9.38

1.4

1.3

—

33.94

—

Peripheral artery disease

239

1244

1.55

9.25

1.5

1.3

—

39.75

—

Pure hyperglyceridaemia

4.23

9.23

1.5

1.2

—

Inflammatory diseases of female pelvic organs

459

2531

1.37

9.20

1.3

35.14

26.68

nmol/l

—

Tonsillectomy and adenotomy

400

1988

1.41

9.20

1.3

32.63

27.83

nmol/l

—

Eating disorder

355

2.16

8.99

1.2

1.3

—

36.38

—

Gonarthrosis, primary, with knee surgery

336

1916

1.44

8.97

1.3

—

39.64

—

Use of cabergoline

5.31

8.95

1.5

1.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

153

864

1.71

8.93

1.2

1.3

—

28.69

—

Conjunctivitis

513

3358

1.33

8.85

1.3

29.56

29.55

nmol/l

—

Septicaemia

230

1444

1.54

8.78

1.4

1.3

—

35.21

—

Explicit Sepsis

247

1574

1.51

8.68

1.4

1.3

—

33.29

—

Other eating disorders

194

2.56

8.50

1.3

—

31.00

—

Malignant neoplasm

609

2776

1.30

8.44

1.3

—

31.22

—

Other septicaemia

204

1286

1.56

8.43

1.4

1.3

—

35.21

—

Epilepsy

167

1023

1.63

8.35

1.3

—

34.55

—

Atherosclerosis, excluding cerebral and coronary sclerosis

215

1116

1.55

8.22

1.4

1.3

—

41.57

—

Gout, FINNGEN

150

901

1.67

8.21

1.4

—

42.83

—

Other neurological diseases

440

2626

1.35

8.18

1.4

1.3

23.20

36.87

nmol/l

—

Abnormal involuntary movements

465

1.95

8.16

1.3

—

36.00

—

Acromegaly and pituitary gigantism

6.81

8.15

1.4

1.3

—

Hypertensive Renal Disease

4.05

8.08

1.9

1.2

—

Eating disorders

441

1.96

7.96

1.2

1.3

—

36.38

—

Benign neoplasm: Pancreas

3.54

7.87

1.3

—

Chronic sinusitis

282

1966

1.44

7.86

1.3

38.17

29.17

nmol/l

—

Injuries to the head

726

3773

1.26

7.62

1.3

32.67

28.97

nmol/l

—

Special screening examination for infectious and parasitic diseases

151

687

1.65

7.53

1.3

46.60

19.57

nmol/l

—

Benign neoplasm: Pancreas

3.41

7.43

1.3

1.2

—

Other congenital malformations

311

2.11

7.32

1.2

1.3

—

36.12

—

Chronic diseases of tonsils and adenoids

542

2657

1.29

7.25

1.3

32.55

26.65

nmol/l

0.34

Other benign neoplasms of skin

219

1451

1.49

7.25

1.3

—

36.25

—

Other noninflammatory disorders of uterus, except cervix

159

674

1.62

7.24

1.3

—

28.00

—

Medical abortion

468

1925

1.33

7.23

1.3

33.40

28.00

nmol/l

—

Bulimia nervosa (incl. atypical)

136

2.69

6.93

1.4

—

33.40

—

Other hearing loss

147

910

1.59

6.73

1.4

1.3

—

34.00

—

Transport accidents

284

1806

1.40

6.73

1.3

35.80

29.47

nmol/l

—

Other and unspecified nerve root and plexus disorders, also in other diseases

121

730

1.67

6.63

1.1

1.3

—

29.22

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

197

1330

1.49

6.60

1.3

35.00

32.15

nmol/l

—

Peroneal tendinitis

4.42

6.53

1.4

1.3

—

ILD medications: immunosuppressive drugs

383

2782

1.32

6.48

1.2

1.3

18.33

30.60

nmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

543

1.76

6.36

1.2

1.4

—

40.50

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

333

1.97

6.16

1.4

1.3

—

31.71

—

Vasomotor and allergic rhinitis

241

1691

1.41

6.10

1.4

1.3

20.71

26.31

nmol/l

—

Postviral fatigue syndrome

4.99

6.03

1.2

1.3

—

Leiomyoma of uterus

338

1416

1.35

6.02

1.4

1.3

41.33

23.50

nmol/l

—

136

768

1.57

5.89

1.3

—

36.00

—

Adjustment and management of implanted device

557

1.71

5.84

1.2

1.3

—

38.60

—

Abdominal aortic aneurysm (AAA)

198

2.22

5.72

1.4

1.3

—

Pregnancy with abortive outcome

471

1946

1.27

5.36

1.3

33.40

28.52

nmol/l

—

Female infertility, associated with anovulation

301

1.94

5.34

1.3

—

35.29

—

Leisure time condition

105

651

1.62

5.26

1.3

—

38.86

—

Psoriasis

175

1213

1.45

5.24

1.2

1.3

19.83

33.27

nmol/l

—

Suppurative and unspecified otitis media

227

1456

1.39

5.23

1.3

28.20

29.74

nmol/l

—

Other benign neoplasms of skin

219

1588

1.38

5.08

1.3

—

33.07

—

Leiomyoma of uterus

437

1964

1.27

5.08

1.4

1.3

41.33

23.62

nmol/l

—

Papulosquamous disorders

237

1747

1.36

4.98

1.2

1.3

19.00

36.53

nmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

375

2821

1.28

4.95

1.3

29.80

29.22

nmol/l

—

In situ neoplasms

200

1368

1.40

4.94

1.3

—

35.44

—

Retention of urine

160

933

1.45

4.83

1.3

—

42.33

—

Carcinoma in situ, bladder

2.78

4.80

1.1

1.3

—

Carcinoma in situ, bladder

2.78

4.80

1.1

1.4

—

Prolonged pregnancy

705

0.49

4.79

1.3

—

34.75

—

Unspecified kidney failure

236

2.00

4.79

1.4

1.3

—

Zoster [herpes zoster]

100

630

1.60

4.74

1.3

—

37.60

—

Umbilical hernia

147

1011

1.46

4.64

1.3

—

31.13

—

Angina pectoris

336

1765

1.29

4.60

1.3

—

41.12

—

Carcinoid syndrome

4.89

4.56

1.5

1.2

—

Certain disorders involving the immune mechanism

116

765

1.52

4.52

1.3

—

31.13

—

Unspecified acute lower respiratory infection

501

1.64

4.43

1.4

1.3

—

24.50

—

Carcinoma in situ of other and unspecified sites

2.62

4.32

1.1

1.2

—

Carcinoma in situ of other and unspecified sites

2.62

4.32

1.1

1.4

—

Atopic dermatitis

349

2358

1.27

4.31

1.4

1.3

25.25

30.08

nmol/l

—

Hyperkalaemia

107

2.45

4.30

1.3

1.2

—

Lateral epicondylitis

499

1.63

4.25

1.3

—

36.00

—

Allergic rhinitis

191

1387

1.37

4.22

1.4

1.3

20.71

30.65

nmol/l

—

Personal history of other diseases and conditions

438

1.67

4.18

1.2

1.3

—

30.10

—

Other problems related to primary support group, including family circumstances

437

1.66

4.14

1.5

1.3

—

28.13

—

Erosion of teeth

3.13

4.11

1.4

1.3

—

Degeneration of macula and posterior pole

230

1433

1.33

4.08

1.4

1.3

—

43.83

—

Cellulitis

119

810

1.47

4.02

1.3

—

32.80

—

Coeliac disease

478

1.62

3.95

1.5

1.3

—

47.80

—

Postmenopausal bleeding

175

693

1.39

3.95

1.2

1.3

—

29.00

—

Major coronary heart disease event

391

2109

1.24

3.93

1.4

1.3

—

34.55

—

Calcaneal spur

3.49

3.93

1.4

1.2

—

Other specified and unspecified disorders of eyelid

3.49

3.93

1.5

1.2

—

Other specified/unspecified dorsopathies

2.47

3.89

1.7

1.3

—

Other maternal disorders predominantly related to pregnancy

403

2058

1.23

3.86

1.3

34.20

27.79

nmol/l

—

Striking against or struck by other objects

182

1345

1.36

3.85

1.3

—

29.30

—

Acne vulgaris

278

1.81

3.83

1.5

1.3

—

30.17

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

560

1.54

3.63

1.3

1.4

—

43.20

—

In situ neoplasms

200

1517

1.32

3.60

1.3

—

32.31

—

Tinnitus

138

990

1.40

3.56

1.2

1.3

—

29.73

—

Fungal Sepsis

111

2.28

3.56

1.7

1.2

—

Abnormality of white blood cells, not elsewhere classified

3.95

3.55

1.0

1.3

—

Spermatocele

171

2.00

3.53

1.3

1.4

—

Collapsed vertebra, not elsewhere classified

6.30

3.52

1.4

1.5

—

Early lumbar disc prolapse, operated

335

1.68

3.37

1.4

1.3

—

26.88

—

Implicit fungal Sepsis

102

2.28

3.30

1.7

1.2

—

Ganglion

120

856

1.41

3.24

1.4

1.3

—

35.63

—

Discitis, unspecified

3.20

3.23

1.1

1.3

—

Follicular cysts of skin and subcutaneous tissue

101

699

1.45

3.22

1.3

—

31.13

—

Gout due to impairment of renal function

3.65

3.22

1.1

1.3

—

Diseases of middle ear and mastoid

340

2281

1.22

3.20

1.3

28.56

28.75

nmol/l

—

Superficial injury of thorax

522

1.52

3.17

1.3

—

35.00

—

Abnormal serum enzyme levels

134

967

1.37

3.13

1.4

1.3

—

39.00

—

Neuroendocrine tumor and carcinoma of pancreas

5.16

3.08

1.4

1.2

—

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

5.16

3.08

1.4

1.2

—

Fatigue fracture of vertebra

7.73

3.08

1.3

1.6

—

Malignant neoplasm of larynx

3.49

3.06

1.1

1.2

—

Other diseases of pericardium

121

2.08

2.93

1.4

1.3

—

Lesion of plantar nerve

250

1.73

2.93

1.5

1.2

—

Gingival hyperplasia

2.34

2.92

1.2

1.3

—

Temporomandibular joint disorders, including avohilmo

261

2106

1.24

2.91

1.4

1.3

26.60

31.13

nmol/l

—

Myocardial infarction, without ST-elevation

174

1233

1.30

2.91

1.5

1.3

—

42.29

—

Benign neoplasm: Endocrine gland, other/unspecified

5.64

2.91

1.3

1.1

—

Benign neoplasm: Endocrine gland, other/unspecified

5.64

2.91

1.3

1.1

—

Left side

6.90

2.89

1.3

—

Charcot foot

2.80

2.83

1.2

1.3

—

Stroke, including SAH

326

1998

1.21

2.77

1.4

1.3

—

34.33

—

Benign neoplasm: Connective and other soft tissue, unspecified

2.91

2.77

1.0

1.3

—

Artificial opening status

152

1.92

2.75

1.1

1.3

—

Urethral stricture

131

2.00

2.75

1.2

1.4

—

Symptoms and signs involving appearance and behaviour

3.83

2.69

1.2

1.5

—

Stroke, excluding SAH

303

1858

1.21

2.68

1.4

1.3

—

35.64

—

Benign neoplasm: Connective and other soft tissue, unspecified

2.84

2.67

1.0

1.3

—

Other disorders of gingiva or/and edentulous alveolar ridge

133

1.97

2.65

1.2

1.3

—

Myocardial infarction

252

1468

1.23

2.63

1.4

1.3

—

42.29

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

679

1.40

2.61

1.3

—

31.57

—

Dental caries 2

475

3214

1.16

2.61

1.2

1.3

27.20

28.68

nmol/l

—

Focal epilepsy

107

783

1.37

2.56

1.3

—

35.22

—

Secondary polycythaemia

2.45

2.55

1.4

1.2

—

Drug-induced headache, not elsewhere classified

4.49

2.50

1.6

1.5

—

Dental caries 2, only avohilmo

466

3173

1.16

2.49

1.2

1.3

27.20

28.68

nmol/l

—

Rosacea

445

1.49

2.49

1.4

1.3

—

33.67

—

Dental caries 2 and operation codes

465

3190

1.16

2.48

1.2

1.3

27.20

28.68

nmol/l

—

Sequelae of cerebrovascular disease

156

1062

1.29

2.47

1.4

1.3

—

41.57

—

Follow-up examination after treatment for malignant neoplasms

310

1.59

2.46

1.2

1.3

—

Cardiac arrest

2.05

2.46

1.9

1.2

—

Sarcoidosis

521

1.45

2.44

1.4

1.3

—

34.00

—

Left bundle-branch block

196

1.74

2.43

1.5

1.3

—

Open wound of wrist and hand

228

1840

1.23

2.41

1.3

—

29.05

—

Other injuries of upper limb, level unspecified

3.39

2.40

1.0

1.4

—

Hypertrophy of (infrapatellar) fat pad

3.39

2.40

1.6

1.3

—

Congenital malformation of biliary tract

6.52

2.40

1.0

1.1

—

Fluid overload

6.51

2.40

1.2

1.4

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

198

1397

1.25

2.37

1.3

—

36.38

—

Diagnoses used for exclusion with ILD

123

935

1.32

2.33

1.4

1.3

—

34.67

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

3.27

2.32

1.3

1.2

—

Atopic dermatitis, strict definition with reimbursement

172

1324

1.26

2.32

1.3

29.00

33.86

nmol/l

—

Allergic conjunctivitis

346

2899

1.18

2.31

1.3

27.80

27.36

nmol/l

—

Benign neoplasm of breast

519

1.43

2.31

1.2

1.3

—

31.13

—

Multiple delivery

434

0.55

2.30

1.2

1.3

—

24.80

—

Acute thyroiditis

4.76

2.29

1.3

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

487

1.44

2.28

1.3

1.4

—

33.67

—

Acidosis

2.58

2.28

1.3

1.2

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

301

1.57

2.27

1.3

—

37.00

—

Benign neoplasm: Brain, unspecified

3.98

2.27

1.1

1.3

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

3.98

2.27

1.0

1.2

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

3.98

2.27

1.0

1.3

—

Melanocytic naevi

155

1220

1.27

2.26

1.2

1.3

—

32.27

—

Parodontitis, under 40 years and operation codes

333

1.54

2.26

1.5

1.3

—

24.57

—

Systemic sclerosis (FG)

2.29

2.25

1.2

1.5

—

Unspecified nephritic syndrome

0.00

2.24

0.0

1.3

—

Magnesium deficiency

5.78

2.24

1.2

1.1

—

Gastrojejunal ulcer

3.14

2.23

1.1

1.4

—

Other and unspecified rosacea

319

1.54

2.21

1.3

1.2

—

33.67

—

Parodontitis, operation under 40 years and operation codes

335

1.53

2.21

1.5

1.3

—

24.57

—

Pollen allergy

104

771

1.34

2.19

1.4

1.3

20.71

33.75

nmol/l

—

Benign neoplasm: Nasopharynx

3.39

2.19

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

326

2733

1.17

2.16

1.3

27.80

26.52

nmol/l

—

Special screening examination for other diseases and disorders

250

1.61

2.15

1.3

—

Focal epilepsy, strict definition

705

1.35

2.14

1.3

—

36.13

—

Hyperosmolality and hypernatraemia

2.74

2.11

1.4

1.3

—

Traumatic subarachnoid haemorrhage

2.22

2.11

1.5

1.3

—

Cicatricial alopecia [scarring hair loss]

3.27

2.11

1.3

—

Parodontitis, under 40 years

356

1.49

2.09

1.5

1.3

—

24.57

—

Parodontitis, under 40 years, or operation codes

356

1.49

2.09

1.5

1.3

—

24.57

—

Reimbursement for rheumatic diseases

329

2811

1.17

2.08

1.3

18.40

32.57

nmol/l

—

Benign neoplasm of other and unspecified intrathoracic organs

2.95

2.08

1.2

1.3

—

Benign neoplasm: Brain, unspecified

3.58

2.07

1.1

1.3

—

Selective deficiency of immunoglobulin G [IgG] subclasses

3.57

2.07

1.1

1.3

—

Endometriosis of rectovaginal septum and vagina

325

1.52

2.06

1.4

1.3

—

25.80

—

Mild or no visual impairment, binocular

4.10

2.05

1.2

—

Primary biliary cholangitis (PBC)

2.20

2.05

1.4

1.3

—

Ischaemic Stroke, excluding all haemorrhages

272

1732

1.19

2.04

1.4

1.3

—

40.38

—

Injury of muscle and tendon at shoulder and upper arm level

177

1436

1.24

2.03

1.4

1.3

—

35.00

—

Spinal osteochondrosis

3.12

2.02

1.9

1.5

—

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

2.87

2.01

1.9

1.3

—

Benign neoplasm of breast

534

1.39

2.01

1.2

1.3

—

33.67

—

Paraplegia, diplegia of upper limbs

2.30

1.98

1.5

1.2

—

Impotence

126

1.84

1.98

1.4

1.3

—

Other and unspecified disorders of adult personality and behaviour

3.41

1.98

1.1

—

Other and unspecified disorders of pigmentation

3.40

1.98

1.1

1.3

—

Syndrome of inappropriate secretion of antidiuretic hormone

3.84

1.95

2.2

1.1

—

Other osteochondrodysplasias

3.01

1.95

1.0

1.4

—

Exophthalmic conditions

3.00

1.94

1.5

1.4

—

Fasciculation

2.76

1.94

1.1

1.2

—

Keratoconus

2.07

1.91

1.0

1.3

—

Benign neoplasm: Nasopharynx

2.90

1.87

1.0

1.2

—

Kyphosis

2.89

1.87

1.0

1.4

—

Isolated proteinuria

2.04

1.86

1.3

—

Explicit fungal Sepsis

3.60

1.85

1.2

1.3

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

2.22

1.85

1.4

1.3

—

Dermatopolymyositis (FG)

2.53

1.84

1.4

—

Paget disease

4.26

1.83

1.4

1.2

—

Benign neoplasm: Endocrine pancreas

4.24

1.83

1.8

1.2

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

2.29

1.81

1.3

1.2

—

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

2.61

1.81

1.3

—

Other bursitis of knee

2.60

1.81

1.4

1.2

—

Other renal tubulo-interstitial diseases

2.02

1.80

1.3

1.4

—

Tibial collateral bursitis [Pellegrini-Stieda]

3.08

1.80

1.0

1.3

—

Iliotibial band syndrome

3.08

1.80

1.4

1.3

—

Dronedarone medication

1.97

1.80

1.5

1.2

—

Other acute viral hepatitis

2.79

1.80

1.8

1.4

—

Major coronary heart disease event excluding revascularizations

328

1959

1.16

1.79

1.4

1.3

—

36.00

—

Varicose veins

350

2302

1.15

1.78

1.3

—

34.06

—

Disorders of synovium and tendon in diseases classified elsewhere

2.19

1.78

1.5

1.3

—

Pericarditis

102

1.87

1.76

1.4

1.2

—

Postzoster neuralgia

2.47

1.76

1.2

1.1

—

Disorders of phosphorus metabolism and phosphatases

3.42

1.76

2.0

1.2

—

Epidural haemorrhage

3.37

1.75

1.0

1.2

—

Benign neoplasm of other and unspecified intrathoracic organs

2.54

1.75

1.2

1.3

—

Other acute disseminated demyelination

2.54

1.75

1.3

1.4

—

Ectopic pregnancy

106

828

1.28

1.73

1.2

1.3

—

32.30

—

Meralgia paraesthetica

110

1.83

1.73

1.1

1.2

—

Diastasis of muscle

2.96

1.73

1.9

1.3

—

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

2.70

1.73

1.0

1.3

—

Rhinophyma

3.91

1.72

1.8

1.1

—

Other rupture of muscle

3.91

1.72

1.2

1.1

—

Other specified/unspecified spondylopathies

2.15

1.72

1.5

1.3

—

Inflammation of lacrimal passages (chronic)

0.00

1.70

0.0

1.2

—

Cardiomyopathy, Hypertrophic obstructive

2.20

1.68

1.3

—

Sequelae of intentional self-harm, assault and events of undetermined intent

3.21

1.67

1.2

1.5

—

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

2.85

1.66

1.7

1.2

—

Bursitis of shoulder

1.99

1.65

1.4

1.2

—

Myositis

1.99

1.65

1.3

1.2

—

Alcohol-induced acute pancreatitis

105

1.82

1.63

1.2

1.3

—

D07AA Corticosteroids, weak (group I)

625

1.31

1.62

1.5

1.3

—

33.67

—

Superficial injury of shoulder and upper arm

411

1.39

1.62

1.4

1.3

—

46.20

—

Tumor necrosis factor alpha inhibitors

583

1.32

1.61

1.2

1.3

19.20

36.38

nmol/l

—

Direct fill therapy

497

1.35

1.60

1.2

1.3

—

46.20

—

Unspecified renal colic

3.05

1.59

1.0

1.3

—

Neuroendocrine tumor and carcinoma of lung

2.74

1.59

1.7

1.2

—

Nail dystrophy

3.05

1.59

1.2

—

Melanocytic naevi

155

1280

1.21

1.58

1.2

1.3

—

31.58

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

116

900

1.25

1.55

1.3

—

44.33

—

Biological medication for rheuma

657

1.30

1.54

1.2

1.3

19.20

36.38

nmol/l

—

Other and unspecified glaucoma

184

1.58

1.54

1.3

—

Actinic keratosis

158

1244

1.21

1.53

1.4

1.3

—

43.83

—

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

3.40

1.53

1.0

1.1

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

3.40

1.53

1.4

1.2

—

Other specified/unspecified diseases of inner ear

3.40

1.53

2.4

1.6

—

Abnormal reflex

3.40

1.53

1.0

1.1

—

Disorders of other and unspecified cranial nerves

3.39

1.53

1.4

1.2

—

Benign neoplasm: Endocrine pancreas

3.39

1.53

1.8

1.2

—

Disorders of pituitary gland, other and/or unspecified

3.39

1.53

1.0

1.2

—

Herpesviral [herpes simplex] infections

450

1.36

1.52

1.2

1.3

—

37.00

—

Liposarcoma, excluding all cancers (controls excluding all cancers)

2.62

1.52

1.0

1.3

—

Inflammatory disorders of male genital organs, not elsewhere classified

2.61

1.52

1.6

1.3

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

2.91

1.51

1.2

1.3

—

Preterm labour and delivery

161

1341

1.20

1.51

1.3

—

33.44

—

Alcohol abuse counselling and surveillance

2.18

1.51

1.3

1.2

—

Idiopathic gout

250

1.49

1.50

1.3

1.4

—

Campylobacter enteritis

1.91

1.50

1.5

1.3

—

Myocardial infarction, strict

220

1371

1.17

1.49

1.3

—

42.29

—

Cardiomyopathy, other and unspecified

226

1.51

1.49

1.3

1.4

—

Endocarditis

1.82

1.47

1.7

1.3

—

Universal erythroderma, KELA reimbursement

2.39

1.46

1.1

1.3

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.53

1.46

1.7

1.4

—

Twin gestation

427

0.65

1.46

1.1

1.3

—

36.33

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

2.13

1.45

1.1

1.3

—

Contact with blunt object, undetermined intent

3.17

1.44

1.0

1.3

—

Defects in the complement system

2.77

1.44

1.8

1.4

—

Pityriasis rosea

2.76

1.44

1.2

—

Folate deficiency anaemia

2.76

1.44

2.3

1.3

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

2.76

1.44

1.0

1.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

533

1.32

1.44

1.3

—

33.67

—

Haemorrhage, not elsewhere classified

1.80

1.43

1.5

1.1

—

Secondary parkinsonism, excluding more controls

2.32

1.43

1.3

—

Atopic dermatitis, strict definition

162

1332

1.19

1.42

1.3

29.00

33.76

nmol/l

—

Other disorders of central nervous system

2.28

1.41

1.0

1.4

—

Spontaneous abortion

283

1686

1.14

1.38

1.3

—

29.00

—

Acquired stenosis of external ear canal

2.64

1.37

1.2

1.1

—

Other bursitis, not elsewhere classified

2.63

1.37

1.7

1.1

—

Diving or jumping into water causing injury other than drowning or submersion

2.99

1.37

1.6

1.2

—

Postmenopausal atrophic vaginitis

143

713

1.21

1.36

1.3

—

26.60

—

Mental disorders, not otherwise specified

340

1.39

1.35

1.0

1.3

—

34.00

—

Primary_lymphoid and hematopoietic malignant neoplasms

786

1.25

1.35

1.2

1.4

—

40.00

—

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

1.88

1.35

1.4

1.3

—

Disorders of optic nerve and visual pathways

349

1.38

1.34

1.5

1.3

—

31.57

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

195

1303

1.17

1.32

1.3

—

38.25

—

Melanocytic naevi of trunk

428

1.34

1.31

1.3

—

38.57

—

Disorders of magnesium metabolism

2.54

1.31

1.0

1.3

—

Recurrent and persistent haematuria

2.53

1.31

1.2

1.4

—

Hereditary motor and sensory neuropathy

2.53

1.31

1.2

1.4

—

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

2.11

1.30

1.3

1.2

—

Assault by blunt object

2.37

1.29

1.6

1.3

—

Gastrointestinal stromal tumor and sarcoma

2.31

1.27

1.0

1.3

—

Striae atrophicae

2.31

1.27

1.3

1.2

—

Benign neoplasm: Bronchus and lung

2.31

1.27

1.4

1.3

—

Skin changes due to chronic exposure to nonionizing radiation

162

1301

1.18

1.27

1.4

1.3

—

43.83

—

Multiple gestation

436

0.69

1.26

1.1

1.3

—

36.33

—

Early lumbar disc prolapse operation

431

1.33

1.26

1.4

1.3

—

31.13

—

Neuroendocrine tumor and carcinoma of small intestine

2.24

1.25

1.5

1.2

—

Hypotension due to drugs

2.24

1.25

1.5

1.2

—

Causalgia

1.98

1.22

1.2

—

Other and unspecified trigeminal disorders

2.06

1.22

1.4

1.2

—

Drug-induced hypoglycaemia without coma

2.18

1.22

1.9

1.3

—

Chronic nephritic syndrome

116

1.65

1.21

1.4

1.3

—

Primary angle-closure glaucoma

132

1.60

1.20

1.4

1.3

—

Right bundle-branch block

101

1.69

1.20

1.2

1.3

—

Blindness, monocular

2.33

1.19

1.2

1.3

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

2.33

1.19

1.0

1.1

—

Sequelae of other accidents

2.12

1.19

1.3

—

Malnutrition

1.94

1.17

1.3

—

Open wound of lower leg

516

1.28

1.17

1.4

1.3

—

36.40

—

Second line medication for Crohn's disease

310

2775

1.12

1.17

1.2

1.3

18.86

32.22

nmol/l

—

Other dermatomyositis

2.54

1.16

1.6

1.1

—

Intentional self-harm by jumping from a high place

2.54

1.16

1.2

1.4

—

Pre-eclampsia superimposed on chronic hypertension

2.54

1.16

1.8

1.4

—

Late syphilis

2.07

1.16

1.4

1.2

—

Fibrosis of liver

2.53

1.15

1.0

1.3

—

Abscess of external ear

2.07

1.15

1.0

1.2

—

Secondary malignant neoplasm of respiratory and digestive organs

0.00

1.15

0.0

1.2

—

Burn and corrosion confined to eye and adnexa

1.82

1.15

1.3

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

265

1604

1.13

1.14

1.3

—

37.67

—

L02BA Anti-estrogens

778

0.78

1.13

1.2

1.3

—

34.14

—

Routine general health check-up of defined subpopulation

1.91

1.12

1.3

—

Medical treatment for female infertility

1040

0.81

1.12

1.3

—

27.82

—

Dermatopolymyositis

1.98

1.12

1.4

1.3

—

Other keratitis

414

1.31

1.11

1.2

1.3

—

33.50

—

Iridocyclitis in diseases classified elsewhere

1.98

1.11

1.1

1.3

—

Injury of urinary and pelvic organs

1.97

1.11

1.1

1.2

—

Osteonecrosis

168

1.49

1.09

1.2

1.3

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

2.41

1.09

1.0

1.1

—

Other congenital malformations of intestine

2.40

1.09

1.6

1.3

—

Other specified/unspecified disorders of bone/cartilage

1.74

1.09

1.1

1.2

—

Other abnormalities of plasma proteins

1.97

1.09

1.1

1.3

—

Congenital malformations of gallbladder, bile ducts and liver

2.21

1.08

1.0

1.3

—

Malignant neoplasm of testis

2.20

1.08

1.0

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

487

1.28

1.08

1.4

—

45.20

—

Acute alcohol intoxication

110

920

1.20

1.07

1.3

—

32.67

—

Panniculitis, unspecified

2.14

1.06

1.1

1.2

—

Coronary revascularization (ANGIO or CABG)

205

1255

1.14

1.05

1.3

—

42.29

—

Cardiac murmurs and other cardiac sounds

293

1.35

1.04

1.5

1.2

—

38.43

—

Liposarcoma

2.30

1.04

1.0

1.1

—

Hypertension, Pulmonary Arterial

2.29

1.04

1.2

1.3

—

Tarsal tunnel syndrome

2.08

1.03

1.1

1.2

—

Use of rotigotine

2.08

1.03

1.0

1.2

—

Melanocytic naevi of trunk

446

1.28

1.03

1.3

—

41.33

—

Carcinoma in situ of colon

2.08

1.03

1.3

1.2

—

L04AX Other immunosuppressants

301

2715

1.11

1.02

1.3

18.33

31.95

nmol/l

—

Guillain-Barre syndrome

1.93

1.02

1.3

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

789

1.21

1.01

1.3

—

43.20

—

Pneumocystosis

1.89

1.01

1.1

1.2

—

Other facial nerve disorders

1.66

1.01

1.3

1.2

—

Arterial embolism and thrombosis of lower extremity artery

1.65

1.00

1.2

1.3

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

2.20

0.98

1.0

1.3

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

2.19

0.98

1.4

1.2

—

Seminoma of testis, excluding all cancers (controls excluding all cancers)

2.19

0.98

1.0

1.3

—

Benign neoplasm: Bladder

2.19

0.98

1.0

1.1

—

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

0.00

0.98

0.0

1.4

—

Anoxic brain damage

0.00

0.97

0.0

1.2

—

Family history of other specific disorders

1.96

0.97

1.7

1.4

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

181

1292

1.14

0.94

1.2

1.3

—

34.73

—

Benign neoplasm: Spinal meninges

1.91

0.94

1.0

1.3

—

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

1.79

0.94

1.4

1.3

—

Arthropathy in ulcerative colitis

1.91

0.94

1.3

1.2

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

2.25

0.94

1.0

1.3

—

severe traumatic brain injury, does not include concussion

696

1.21

0.94

1.3

1.4

—

40.83

—

Haemorrhagic disorder due to circulating anticoagulants

2.24

0.94

1.3

1.1

—

Infection of intervertebral disc (pyogenic)

2.24

0.94

1.0

1.1

—

Lesion of lateral popliteal nerve

150

1.47

0.93

1.5

1.2

—

Androgenic alopecia

2.17

0.92

2.3

1.3

—

Disorders of brain, other and unspecified

2.16

0.92

1.2

1.3

—

Type 1 diabetes, definitions combined

304

1.31

0.90

1.5

1.3

—

33.63

—

Leiomyosarcoma

2.10

0.90

1.5

1.3

—

Polymyositis

2.09

0.90

1.2

1.3

—

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

1.92

0.89

1.5

1.2

—

Other necrotizing vasculopathies (FG)

160

1.44

0.89

1.1

1.4

—

Other congenital malformations of circulatory system

1.65

0.88

1.1

1.3

—

Other/unspecified seropositive rheumatoid arthritis

101

1185

0.85

0.88

1.2

1.3

—

29.40

—

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

2.02

0.87

1.5

1.3

—

Other disorders of amniotic fluid and membranes

669

1.20

0.87

1.4

1.3

—

36.55

—

Dependence on enabling machines and devices, not elsewhere classified

2.01

0.87

1.0

1.3

—

Anogenital herpesviral [herpes simplex] infection

238

1.35

0.86

1.3

—

34.00

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

100

1170

0.85

1.2

1.3

—

29.40

—

Peptic ulcer

1.95

0.84

1.3

1.4

—

Other specified and unspecified strabismus

1.95

0.84

1.5

1.3

—

Adult respiratory distress syndrome

1.95

0.84

1.7

1.2

—

Cauda equina syndrome

1.79

0.84

2.3

1.2

—

Seropositive rheumatoid arthritis, wide

103

1201

0.86

0.84

1.2

1.3

—

29.40

—

Type 1 diabetes, strict (exclude DM2)

300

1.30

0.82

1.4

1.3

—

33.63

—

Other immunodeficiencies

1.89

0.82

1.8

1.3

—

Ankylosing hyperostosis [Forestier]

1.89

0.82

1.5

1.3

—

Rheumatoid arthritis, including avohilmo

158

1783

0.89

0.81

1.2

1.3

—

35.38

—

Heart failure and hypertrophic cardiomyopathy

1.71

0.81

3.4

1.4

—

Complications of labour and delivery

350

2118

0.92

0.79

1.3

31.33

29.63

nmol/l

—

Multifocal fibrosclerosis

0.00

0.79

0.0

1.2

—

Lung transplant status

0.00

0.79

0.0

1.4

—

Lung transplantation

0.00

0.79

0.0

1.4

—

Isolated proteinuria with specified morphological lesion

1.83

0.79

1.0

1.2

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.83

0.79

1.3

1.2

—

Inhalation and ingestion of food causing obstruction of respiratory tract

0.00

0.79

0.0

1.3

—

Somnolence

1.83

0.79

1.0

1.1

—

Exposure to excessive natural cold

0.00

0.79

0.0

1.2

—

Bitten or struck by other mammals

437

1.24

0.79

1.5

1.3

—

36.12

—

Organic, including symptomatic, mental disorders

166

1347

0.89

0.79

1.4

1.3

—

37.86

—

Shock, not elsewhere classified

0.00

0.77

0.0

1.2

—

Other disorders of prostate

1.65

0.75

1.5

1.3

—

Pathological resorption of teeth

1.57

0.75

1.0

1.2

—

Seminoma of testis

2.10

0.75

1.0

1.3

—

Disease of hard tissues of teeth, NOS

2.10

0.74

1.4

—

Type 1 diabetes, strict definition

235

1.32

0.74

1.5

1.3

—

28.17

—

Abnormal findings on antenatal screening of mother

333

1.26

0.74

1.5

1.3

—

27.67

—

Benign neoplasm: Spinal meninges

1.86

0.74

1.0

1.2

—

Hypermetropia

236

1.32

0.74

1.2

1.3

—

32.40

—

Dialysis

108

1.49

0.73

1.3

—

Neurofibromatosis, type 1

2.02

0.73

1.2

1.3

—

Acute drug-induced interstitial lung disorder

2.02

0.73

1.0

1.2

—

Intercostal neuropathy

2.02

0.73

1.2

1.1

—

Pigmented purpuric dermatosis

2.01

0.73

1.2

1.6

—

Foreign body in genitourinary tract

2.01

0.73

1.6

1.3

—

Other nutritional anaemias

2.01

0.73

1.0

1.4

—

Acute alcohol intoxication, ICD10

745

1.17

0.73

1.3

—

34.89

—

Other factor of the environment

1.81

0.72

1.1

1.3

—

Toxic effect of other and unspecified substances

1.81

0.72

1.1

1.3

—

Hepatocellular carcinoma

1.80

0.72

1.1

1.2

—

Aphakia

1.80

0.72

1.1

1.2

—

Other degenerative diseases of the nervous system

100

655

1.16

0.72

1.4

1.3

—

35.13

—

Noise effects on inner ear

110

0.54

0.72

1.2

1.3

—

Carcinoma in situ of colon

1.76

0.71

1.3

—

Horner syndrome

1.76

0.71

1.1

1.3

—

Other abnormal findings in urine

1.76

0.71

1.1

1.3

—

Contact with lifting and transmission devices, not elsewhere classified

1.59

0.71

1.6

1.3

—

Primary_lymphoid and hematopoietic malignant neoplasms

849

1.16

0.71

1.2

1.3

—

45.20

—

Benign neoplasm: Other parts of oropharynx

1.94

0.71

1.0

1.3

—

Calcific tendinitis

1.94

0.71

1.6

1.3

—

Assault by other specified means

1.94

0.71

1.0

1.3

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

1.93

0.71

1.2

1.3

—

Benign neoplasm: Bladder

1.93

0.71

1.0

1.1

—

Other specific arthropathies, wide

1.56

0.70

1.8

1.4

—

Other disorders starting during childhood or adolescence

159

1.38

0.69

1.1

1.2

—

28.40

—

Other disorders of male genital organs

1.53

0.69

1.2

1.4

—

Malignant neoplasm of bone and articular cartilage

1.87

0.68

1.4

—

Mental and behavioural disorders of puerperium, not classified elsewhere

1.68

0.68

1.0

1.3

—

Carcinoma in situ of skin of ear and external auricular canal

1.86

0.68

1.0

1.2

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.67

0.68

1.0

1.4

—

Amputation of ankle bones

1.53

0.68

2.4

1.3

—

Malignant neoplasm, without specification of site

1.60

0.68

1.5

1.3

—

Coronary angioplasty

154

1058

1.12

0.67

1.2

1.3

—

46.17

—

Benign neoplasm: Pharynx, unspecified

1.80

0.66

1.4

1.3

—

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

1.80

0.66

1.4

—

Other forms of systemic lupus erythematosus

1.80

0.66

1.0

1.4

—

Mental and behavioural disorders associated with the puerperium

1.60

0.65

1.0

1.4

—

Alzheimer’s disease (Atypical or mixed)

178

0.67

0.65

1.4

1.3

—

Malignant neoplasm of liver and intrahepatic bile ducts

1.58

0.65

1.2

1.3

—

Benign neoplasm: Other parts of oropharynx

1.74

0.64

1.0

1.2

—

Use of dimethyl fumarate

1.74

0.64

1.2

1.4

—

Cerebral atherosclerosis

1.73

0.63

1.2

1.4

—

Type 1 diabetes, strict definition, subgroup 1

224

1.29

0.63

1.4

1.3

—

29.40

—

Other menopausal disorders

154

798

1.11

0.62

1.4

1.3

—

25.29

—

Retinal detachments and breaks

154

1390

1.11

0.61

1.3

—

35.30

—

Benign neoplasm: Scapula and long bones of upper limb

1.68

0.61

1.2

—

Carcinoma in situ of skin, other sites/unspecified

1.68

0.61

2.0

1.3

—

Benign neoplasm: Orbit, unspecified

0.00

0.60

0.0

1.3

—

Benign neoplasm: Orbit, unspecified

0.00

0.60

0.0

1.4

—

Cleft lip and cleft lip and palate

0.00

0.60

0.0

1.6

—

Vascular dementia (multiple infarctions)

0.00

0.60

0.0

1.3

—

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

0.00

0.59

0.0

1.2

—

Anorexia (incl.atypical)

245

1.27

0.59

1.1

1.3

—

31.00

—

Prophylactic surgery

0.00

0.58

0.0

1.4

—

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

0.00

0.58

0.0

1.3

—

Toxic effects of substances chiefly nonmedicinal as to source

409

1.20

0.58

1.2

1.3

—

38.43

—

Acute nephritic syndrome

1.49

0.57

1.1

1.2

—

Pulmonary oedema

1.67

0.56

1.5

1.1

—

Malignant neoplasm of tonsil

1.63

0.55

1.0

1.3

—

TMD related operations

737

1.14

0.55

1.2

1.3

—

32.80

—

Amputation of foot

1.54

0.55

2.7

1.2

—

Torsion of testis

1.58

0.54

1.3

1.4

—

Malignant neoplasm of digestive organs

148

1324

1.10

0.54

1.3

—

37.00

—

Basal cell carcinoma

212

1827

0.92

0.53

1.3

—

39.13

—

Atypical mycobacterium lung infection

1.55

0.53

1.3

1.1

—

Lifestyle-related condition

1.55

0.53

1.2

1.3

—

Other (seronegative) rheumatoid arthritis, wide

792

0.87

0.53

1.3

—

35.00

—

Premature separation of placenta [abruptio placentae]

0.62

0.52

2.2

1.3

—

37.00

—

Dislocation, sprain and strain of joint and ligaments of hip

100

1.40

0.52

1.2

1.3

—

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

1.41

0.51

1.1

1.3

—

Tularaemia

1.47

0.50

1.2

1.3

—

Antepartum haemorrhage, not elsewhere classified

401

0.82

0.50

1.4

1.3

—

42.17

—

L02BG Aromatase inhibitors

151

1382

1.09

0.50

1.3

—

34.70

—

Other bursal cyst

1.56

0.49

1.0

1.2

—

Special screening examination for neoplasms

110

1.37

0.48

1.3

1.4

—

Carcinoma in situ of other and unspecified digestive organs

1.45

0.48

1.5

1.3

—

Pemphigoid

1.45

0.48

1.2

1.3

—

Renal cell carcinoma of kidney

1.40

0.48

1.3

—

Alzheimer’s disease (Late onset), excluding more controls

252

0.82

0.47

1.6

1.2

—

Family history of malignant neoplasm

438

1.17

0.47

1.2

1.3

—

32.60

—

Toxic effect of carbon monoxide

1.46

0.47

1.4

1.3

—

Demyelinating diseases of the central nervous system

355

1.19

0.47

1.3

—

31.57

—

Placenta praevia

199

0.75

0.46

1.1

1.3

—

37.00

—

Unstable angina pectoris

155

1181

1.09

0.46

1.4

1.3

—

38.75

—

Dissocial personality disorder

1.43

0.46

1.0

1.3

—

Injury of eye and orbit

514

1.15

0.46

1.2

1.3

—

34.67

—

Infective bursitis

0.62

0.46

1.2

1.3

—

Acute appendicitis, with complications

770

1.12

0.44

1.2

1.4

—

31.25

—

Basal cell carcinoma, including avohilmo

221

1860

0.93

0.44

1.2

1.3

—

37.89

—

Small cell lung cancer

1.38

0.44

1.1

1.2

—

Small cell lung cancer, helper endpoint

1.38

0.44

1.1

1.2

—

Use of antiglaucoma preparations and miotics

229

1.22

0.43

1.4

1.3

—

Preparation and fitting of bite rail to mouth

583

1.13

0.43

1.1

1.3

—

36.13

—

Benign neoplasm: Scapula and long bones of upper limb

1.62

0.43

1.2

—

Exfoliative dermatitis

1.62

0.43

1.4

1.3

—

Bullous pemphigoid

1.43

0.42

1.3

—

Embolic stroke with flimmer

1.43

0.42

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

592

1.13

0.42

1.5

1.3

—

33.89

—

Alcohol abuse, main dg

565

1.13

0.42

1.2

1.3

—

37.13

—

Exposure to unspecified smoke, fire and flames

1.57

0.42

1.8

1.3

—

Carcinoma in situ of skin, other sites/unspecified

1.57

0.42

2.0

1.1

—

Carcinoma in situ of skin of ear and external auricular canal

1.57

0.42

1.0

1.4

—

Dementia due to Parkinsons disease, excluding more controls

1.57

0.42

1.6

1.3

—

Carcinoma in situ of skin of lower limb, including hip

1.41

0.42

1.5

1.2

—

Lack of expected normal physiological development

1.56

0.42

1.0

1.2

—

Burns and corrosions of multiple and unspecified body regions

1.41

0.42

1.6

1.2

—

Use of levodopa decarbox-comt-inhibitor

0.63

0.42

1.2

1.3

—

Other benign neoplasm of uterus: Other parts/unspecified

139

0.72

0.42

1.0

1.3

—

Cerebral amyloid angiopathy

0.00

0.41

0.0

1.4

—

Adult-onset Still disease

0.00

0.41

0.0

1.6

—

Benign neoplasm: Short bones of lower limb

1.52

0.41

1.0

1.3

—

Benign neoplasm: Short bones of lower limb

1.52

0.41

1.0

1.3

—

Acquired absence of organs, not elsewhere classified

1.52

0.41

1.0

1.2

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.41

0.0

1.3

—

Brain astrocytoma

0.00

0.41

0.0

1.4

—

Congenital hydrocephalus

0.00

0.41

0.0

1.5

—

Chronic myringitis

0.00

0.41

0.0

1.1

—

Maxillary prognathism

0.00

0.41

0.0

1.2

—

Superficial frostbite

0.00

0.41

0.0

1.5

—

Carcinoma in situ of skin of upper limb, including shoulder

1.36

0.41

1.1

1.2

—

Other and specified injuries of hip and thigh

1.36

0.41

1.0

1.2

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.41

0.0

1.1

—

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.3

—

Hypersensitivity angiitis

0.00

0.41

0.0

1.4

—

Other specified transport accidents

0.00

0.41

0.0

1.5

—

ILD medications: nintedanib

0.00

0.41

0.0

1.1

—

Mental and behavioural disorders due to hallucinogens

0.00

0.41

0.0

1.5

—

Amoebiasis

0.00

0.41

0.0

1.5

—

Cleft lip and palate

0.00

0.41

0.0

1.4

—

Use of entacapone

0.00

0.41

0.0

1.1

—

Other papulosquamous disorders

1.48

0.40

1.8

1.4

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

1.32

0.39

1.0

1.3

—

Carcinoma in situ of skin of upper limb, including shoulder

1.31

0.39

1.1

1.4

—

Medicines for HER+ breast cancer

190

1732

1.07

0.39

1.2

1.3

—

33.55

—

Melanoma in situ of other and unspecified parts of face

1.43

0.39

1.6

1.2

—

Lagophthalmos

1.43

0.39

1.6

1.3

—

Dislocation of lens

1.43

0.39

1.6

1.2

—

Adenocarcinomas of cervix

0.00

0.39

0.0

1.4

—

Moderate mental retardation

0.00

0.39

0.0

1.5

—

Other and unspecified hypertrophic disorders of skin

0.00

0.39

0.0

1.3

—

Polyarteritis nodosa

0.00

0.39

0.0

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

210

1764

0.94

0.39

1.3

—

37.89

—

Melanoma in situ of other and unspecified parts of face

1.39

0.38

1.6

1.2

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.39

0.38

1.2

—

Malignant neoplasm of rectosigmoid junction

1.39

0.38

1.0

1.1

—

Malignant neoplasm of breast, HER-positive

180

1661

1.07

0.38

1.2

1.3

—

36.44

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

1.39

0.37

1.1

1.3

—

Chronic lymphocytic leukaemia, helper endpoint

1.39

0.37

1.1

1.3

—

Alzheimer’s disease, wide definition, excluding more controls

278

0.86

0.37

1.5

1.2

—

Myeloid leukaemia

1.27

0.36

1.0

1.2

—

Postpartum haemorrhage due to retained placenta

534

0.88

0.36

1.4

1.3

—

29.67

—

Adenocarcinoma of pancreas

0.66

0.36

1.0

1.3

—

Malignant neoplasm of oropharynx

1.40

0.35

1.0

1.2

—

Sexual dysfunction

1.34

0.34

1.3

1.2

—

Benign neoplasm of male genital organs

1.34

0.34

1.2

1.3

—

Open bite

177

0.79

0.33

1.0

1.3

—

30.17

—

MS-disease / Multiple Sclerosis

303

1.16

0.33

1.3

—

34.00

—

Central retinal artery occlusion

1.28

0.32

1.2

1.3

—

Injury of muscle and tendon at lower leg level

531

1.11

0.31

1.5

1.3

—

32.43

—

Schizophrenia

618

1.10

0.31

1.3

—

29.22

—

Circumscribed brain atrophy

1.32

0.31

1.4

1.2

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

0.71

0.30

1.0

1.4

—

Unspecified lump in breast

736

0.91

0.30

1.3

—

32.88

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

1.34

0.30

1.0

1.4

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.28

0.30

1.3

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

1.25

0.29

1.3

—

Malignant neoplasm of tongue

1.23

0.29

1.4

1.3

—

Non-small cell lung cancer, squamous, helper endpoint

108

0.74

0.29

1.8

1.3

—

Non-small cell lung cancer, squamous

108

0.74

0.29

1.8

1.3

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

1.23

0.29

1.1

1.3

—

Seropositive rheumatoid arthritis, strict definition

636

0.91

0.27

1.2

1.3

—

33.67

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

214

1400

1.05

0.26

1.3

—

43.44

—

Rheumatoid arthritis

142

1219

1.06

0.26

1.2

1.3

—

41.63

—

Anaemia in chronic diseases classified elsewhere

1.20

0.26

1.1

1.3

—

Carcinoma in situ of skin of trunk

1.25

0.25

1.3

1.5

—

Lesion of sciatic nerve

123

1.22

0.25

1.2

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

119

0.80

0.25

1.2

—

Myeloid leukaemia

1.19

0.24

1.0

1.3

—

Inflammatory disorders of breast

274

1.13

0.24

1.5

1.3

—

34.00

—

Other lesions of median nerve

0.71

0.24

1.0

1.2

—

Pulmonary eosinophilia, not elsewhere classified

1.32

0.23

1.2

1.3

—

Hypertrophy of tongue papillae

1.32

0.23

1.6

1.3

—

Measles

1.32

0.23

1.4

—

Open wound of thorax

1.32

0.23

1.0

1.3

—

Emergency coronary revascularization (for ACS)

218

1503

1.04

0.23

1.3

—

38.75

—

Other and unspecified mononeuropathies of lower limb

1.25

0.22

1.7

1.3

—

Kidney transplant status

153

1.18

0.22

1.1

1.3

—

Chronic lymphocytic leukaemia

1.27

0.22

1.1

1.3

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.22

0.0

1.1

—

Drug-induced aplastic anaemia

0.00

0.21

0.0

1.1

—

Aortic arch syndrome [Takayasu]

0.00

0.21

0.0

1.2

—

Mechanical strabismus

0.00

0.21

0.0

1.5

—

Eclampsia

0.00

0.21

0.0

1.3

—

Diseases of thymus

0.00

0.21

0.0

1.3

—

Other cranial nerve disorders in other disorders

0.00

0.21

0.0

1.2

—

Carcinoma in situ of skin of lip

0.00

0.21

0.0

1.1

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.21

0.0

1.2

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.21

0.0

1.4

—

Injury of blood vessels at forearm level

0.00

0.21

0.0

1.3

—

Choroidal haemorrhage and rupture

0.00

0.21

0.0

1.4

—

Explosion of other materials

0.00

0.21

0.0

1.4

—

Unspecified multiple injuries

0.00

0.21

0.0

1.4

—

Maxillary hypoplasia

0.00

0.21

0.0

1.1

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.21

0.0

1.4

—

Internuclear ophthalmoplegia

0.00

0.21

0.0

1.4

—

Down's syndrome

0.00

0.21

0.0

1.2

—

Open wounds involving multiple body regions

0.00

0.21

0.0

1.4

—

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.5

—

Atrioventricular septal defect

0.00

0.21

0.0

1.6

—

Benign neoplasm: Lower jaw bone

0.00

0.21

0.0

1.5

—

Nezelof syndrome

0.00

0.21

0.0

1.6

—

Malignant neoplasm of gallbladder

0.00

0.21

0.0

1.2

—

Other operation for atrial fibrillation

0.00

0.21

0.0

1.1

—

Alcoholic cardiomyopathy

0.00

0.21

0.0

1.1

—

Sequelae of burns, corrosions and frostbite

0.00

0.21

0.0

1.1

—

Dengue fever [classical dengue]

0.00

0.21

0.0

1.4

—

Abnormalities of ear ossicles

0.00

0.21

0.0

1.4

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.21

0.0

1.4

—

Other leukaemias of specified cell type

0.00

0.21

0.0

1.1

—

Other leukaemias of specified cell type

0.00

0.21

0.0

1.2

—

False labour

170

1021

1.05

0.21

1.4

1.3

18.60

32.07

nmol/l

—

Restrictive cardiomyopathy

0.00

0.21

0.0

1.5

—

Other and unspecified water transport accidents

0.00

0.21

0.0

1.4

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

0.21

0.0

1.4

—

Other or unspecified immunodeficiency

0.00

0.21

0.0

1.2

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.00

0.21

0.0

1.1

—

Hypersplenism

0.00

0.21

0.0

1.4

—

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Benign neoplasm: Eye, unspecified

0.00

0.21

0.0

1.3

—

Benign neoplasm: Eye, unspecified

0.00

0.21

0.0

1.2

—

Listeriosis

0.00

0.21

0.0

1.1

—

Malignant neoplasm of anus and anal canal

0.00

0.21

0.0

1.4

—

Hypothermia

1.16

0.21

1.0

1.3

—

Injury of blood vessels at hip and thigh level

0.00

0.21

0.0

1.3

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

0.00

0.21

0.0

1.1

—

Benign neoplasm: Lower jaw bone

0.00

0.21

0.0

1.4

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.21

0.0

1.2

—

Blindness or visual impairment, binocular

0.00

0.21

0.0

1.2

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

0.21

0.0

1.2

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.21

0.0

1.2

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

1.24

0.21

1.0

1.4

—

Malignant neoplasm of lip

0.00

0.21

0.0

1.2

—

Biliary cirrhosis, NAS

0.00

0.20

0.0

1.1

—

Pediculosis and phthiriasis

0.00

0.20

0.0

1.4

—

Colour vision deficiencies

0.00

0.20

0.0

1.4

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.20

0.0

1.1

—

Acute lymphocytic leukaemia

0.00

0.20

0.0

1.4

—

Acute lymphocytic leukaemia, helper endpoint

0.00

0.20

0.0

1.6

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.6

—

Other congenital malformations of heart

0.00

0.20

0.0

1.2

—

Other specified/unspecified deforming dorsopathies

1.23

0.20

1.3

1.2

—

Inflammation of lacrimal passages (acute and unspecified)

1.20

0.19

1.3

—

Spinal enthesopathy

1.20

0.19

1.2

1.3

—

Benign neoplasm of male genital organs

1.16

0.19

1.2

—

Schizoid personality disorder

1.13

0.18

1.2

1.3

—

Burn and corrosion of head and neck

1.21

0.18

1.6

1.3

—

Carcinoma in situ of cervix uteri

394

0.91

0.18

1.3

—

36.13

—

Other bursitis of hip

1.19

0.18

1.4

1.2

—

Tuberculosis of other organs

1.17

0.18

1.3

1.2

—

Cytomegalovirus infection, IBD co-morbidity

1.15

0.17

1.9

1.2

—

Toxic effect of alcohol

1.15

0.17

1.0

1.2

—

Vascular dementia (subcortical)

1.15

0.17

1.6

1.3

—

Lesion of radial nerve

110

1.18

0.17

1.2

—

Diabetic retinopathy, strict definition

112

939

1.05

0.17

1.2

1.4

—

22.90

—

Injury of nerves and spinal cord at neck level

0.71

0.16

1.0

1.3

—

Adenocarcinoma and papillary adenocarcinoma of stomach

1.18

0.16

1.8

1.3

—

Malignant neoplasm of oral cavity

101

1.19

0.16

1.3

1.2

—

Alzheimer’s disease (Early onset), excluding more controls

1.16

0.16

1.4

1.3

—

Tooth agenesis EXCLUDE clefts and syndromes

120

1.17

0.16

1.1

1.3

—

32.40

—

Foreign body on external eye

496

1.07

0.16

1.5

1.3

—

26.00

—

Other arterial embolism and thrombosis

1.16

0.15

1.4

1.3

—

Carcinoma in situ of skin of trunk

1.14

0.15

1.3

—

Other puerperal infections

342

1.08

0.15

1.1

1.3

—

27.75

—

Congenital malformations of heart and great arteries

446

0.93

0.14

1.7

1.3

—

40.83

—

Failed induction of labour

246

1.10

0.14

1.2

1.3

—

42.80

—

Injury of muscle and tendon at wrist and hand level

469

1.07

0.14

1.3

—

39.20

—

Tuberculosis, IBD comorbidity

202

0.89

0.14

1.1

1.3

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

0.82

0.13

1.8

1.4

—

Use of galantamine

149

0.87

0.13

1.5

1.3

—

Tooth eruption problems

543

0.95

0.12

1.3

—

31.36

—

Other ill-defined and unspecified causes of mortality

153

1.11

0.11

1.2

1.3

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.14

0.10

1.6

1.1

—

Maternal care for other known or suspected fetal problems

127

838

0.97

0.10

1.4

1.3

—

32.07

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.11

0.10

1.2

1.3

—

Alzheimer disease, excluding more controls

323

0.95

0.09

1.4

1.3

—

Coronary artery bypass grafting

677

0.97

0.09

1.5

1.4

—

38.80

—

Malignant neoplasm of skin

267

1975

1.02

0.09

1.3

—

36.69

—

Injury of muscle and tendon at forearm level

1.11

0.09

1.0

1.3

—

Certain zoonotic bacterial diseases

1.07

0.08

1.2

1.3

—

malignant neoplasm of female genital organs

644

0.96

0.08

1.2

1.3

—

33.67

—

Human immunodeficiency virus [HIV] disease

1.05

0.08

1.0

1.2

—

Obstructed labour due to maternal pelvic abnormality

765

0.97

0.08

1.3

—

35.80

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

0.81

0.08

1.8

1.4

—

Carcinoma in situ of skin of scalp and neck

0.81

0.08

1.0

1.3

—

Vascular dementia (undefined)

0.82

0.08

1.4

1.3

—

Carcinoma in situ of cervix uteri

379

0.95

0.08

1.3

—

36.13

—

Tuberculosis of other organs, strict

1.09

0.08

1.3

—

Polyhydramnios

195

0.92

0.08

1.4

—

37.00

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

1.07

0.07

1.1

1.3

—

Rare circulating lymphoid malignancy

1.07

0.07

1.1

1.3

—

Progressive vascular leukoencephalopathy

0.87

0.07

1.0

1.3

—

Other and unspecified mononeuropathies, also in other diseases

1.06

0.07

1.0

1.2

—

Distal bite

102

0.88

0.06

1.8

1.3

—

26.50

—

Erectile dysfunction

187

1.07

0.06

1.3

—

Seropositive rheumatoid arthritis

103

1006

1.02

0.06

1.2

1.3

—

22.67

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

768

1.02

0.05

1.2

1.3

—

33.25

—

Pedal cyclist injured in noncollision transport accidents

414

0.97

0.05

1.2

1.3

—

36.40

—

Seborrhoeic keratosis

863

1.02

0.04

1.3

—

41.83

—

Status post-ami

123

0.93

0.04

1.4

—

LSIL lesion of the cervix uteri

517

1.03

0.04

1.5

1.3

—

32.70

—

Cholera

159

0.94

0.03

1.3

1.2

—

Embedded teeth, including avohilmo

349

0.97

0.02

1.4

1.3

—

31.00

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

201

1374

1.01

0.02

1.2

1.3

—

41.10

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

889

0.99

0.01

1.3

—

34.17

—

Type1 diabetes, definitions combined, early onset

232

1.03

0.01

1.6

1.3

—

30.17

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

194

1345

0.99

0.01

1.3

—

43.44

—

Certain conditions originating in the perinatal period

242

1.03

0.01

1.3

—

32.40

—

Vascular dementia

158

1.04

0.01

1.4

1.3

—

Prepatellar bursitis

114

1.05

0.00

1.3

—

Acute bronchiolitis

140

1.03

0.00

1.1

1.2

—

28.40

—

L02BB Anti-androgens

195

0.97

0.00

1.1

1.3

—

Glaucoma, exfoliation

321

1.00

0.00

1.1

1.3

—

Complications of the puerperium, not elsewhere classified

166

1.02

0.00

1.4

1.3

—

24.20

—

Glaucoma secondary to other eye disorders

112

0.98

0.00

1.7

1.3

—

Benign mammary dysplasia

651

1.00

0.00

1.3

—

35.00

—

Congenital malformations of the circulatory system

493

1.00

0.00

1.5

1.3

—

38.14

—

Unspecified hairloss

0.00

0.0

1.3

—

Other effects of reduced temperature

0.00

0.0

1.6

—

Fracture of spine, level unspecified

0.00

0.0

1.6

—

Renal agenesis and other reduction defects of kidney

0.00

0.0

1.3

—

Syndactyly

0.00

0.0

1.0

—

Other congenital malformations of male genital organs

0.00

0.0

1.4

—

Dementia due to Parkinson's disease

0.96

0.00

1.6

1.3

—

Intentional self-harm by smoke, fire and flames

0.00

0.0

2.0

—

Use of riluzole

0.00

0.0

1.2

—

Pneumoconiosis due to other inorganic dusts

0.00

0.0

1.2

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

1.8

—

Pemphigus foliaceus

0.00

0.0

1.2

—

Degenerative conditions of globe

0.00

0.0

1.0

—

Autoimmune polyglandular failure

0.00

0.0

1.0

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.0

1.3

—

Congenital and developmental myasthenia

0.00

0.0

1.0

—

Food allergy

0.00

0.0

1.0

—

Lipodystrophy, not elsewhere classified

0.00

0.0

1.3

—

Telogen effluvium

0.00

0.0

1.4

—

Qualitative platelet defects

0.00

0.0

1.4

—

Haemophilus septicemia

0.00

0.0

1.0

—

Carcinoma in situ of larynx

0.00

0.0

1.2

—

Benign neoplasm: Epididymis

0.00

0.0

1.0

—

Acquired coagulation factor deficiency

0.00

0.0

1.3

—

Kaposi sarcoma

0.00

0.0

1.5

—

Congenital myopathies

0.00

0.0

1.2

—

Glanders and melioidosis

0.00

0.0

1.7

—

Other mosquito-borne viral fevers

0.00

0.0

1.1

—

Haemolytic-uraemic syndrome

0.00

0.0

1.1

—

Abscess of mediastinum

0.00

0.0

1.3

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.0

—

Juvenile dermatomyositis

0.00

0.0

1.0

—

Melanoma in situ of scalp and neck

0.00

0.0

1.2

—

Intermittent hydrarthrosis

0.00

0.0

1.7

—

Osteomyelitis of vertebra

0.00

0.0

1.1

—

Thyroid crisis or storm

0.00

0.0

1.2

—

Other conditions related to polyarteritis nodosa

0.00

0.0

1.2

—

Exposure to high-pressure jet

0.00

0.0

1.6

—

Protrusioacetabuli

0.00

0.0

1.7

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

0.0

1.5

—

Carcinoma in situ of skin of scalp and neck

0.93

0.00

1.0

1.4

—

Sexual assault by bodily force

0.00

0.0

1.1

—

Cyst of spleen

0.00

0.0

1.3

—

Operations 1 for CAVS

0.00

0.0

1.3

—

Intentional self-harm by crashing of motor vehicle

0.00

0.0

1.6

—

Malignant otitis externa

0.00

0.0

1.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

0.88

0.00

1.3

—

Examination and encounter for administrative purposes

110

1.00

0.00

1.3

1.4

—

Severe bullous disorders, KELA reimbursement

0.00

0.0

1.2

—

Hypotony of eye

0.00

0.0

1.0

—

Disorders of optic chiasm

0.00

0.0

1.0

—

Other degenerative disorders of eyelid and periocular area

0.00

0.0

1.1

—

Calcification and ossification of muscle

0.00

0.0

1.2

—

Non-neuropathic heredofamilial amyloidosis

0.00

0.0

2.0

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.0

1.7

—

Victim of lightning

0.00

0.0

1.0

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

0.0

1.0

—

Idiopathic progressive neuropathy

0.00

0.0

1.2

—

Injury of muscle and tendon at neck level

0.00

0.0

1.0

—

Mental and behavioural disorders due to cocaine

0.00

0.0

1.4

—

Sequelae of malnutrition and other nutritional deficiencies

0.00

0.0

1.1

—

Choroidal detachment

0.00

0.0

1.0

—

Exposure to high and low air pressure and changes in air pressure

0.00

0.0

1.6

—

Blindness (ICD-9)

0.00

0.0

1.2

—

Erectile dysfunction, exclusion

0.00

0.0

1.4

—

Nutritional and metabolic disorders in diseases classified elsewhere

0.00

0.0

1.2

—

Failure in dosage during surgical and medical care

0.00

0.0

1.4

—

Disease of thymus, other/unspecified

0.00

0.0

1.4

—

Rheumatoid lung disease

0.00

0.0

1.1

—

Other infestations

0.00

0.0

1.3

—

Other cestode infections

0.00

0.0

1.1

—

Defects in post-translational modification of lysosomal enzymes

0.00

0.0

1.6

—

Sequelae of hyperalimentation

0.00

0.0

1.7

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

0.0

1.0

—

Exposure to sunlight

0.00

0.0

1.2

—

General hospital and personal-use devices associated with adverse incidents

0.00

0.0

1.0

—

Organ-limited amyloidosis

0.00

0.0

1.4

—

Other and unspecified thalassaemias

0.00

0.0

2.0

—

Selective deficiency of immunoglobulin M [IgM]

0.00

0.0

1.4

—

Disorders of endocrine glands in diseases classified elsewhere

0.00

0.0

1.0

—

L02BX Other hormone antagonists and related agents

130

1.00

0.00

1.4

1.3

—

Other congenital malformations of spinal cord

0.00

0.0

1.1

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.00

0.0

1.3

—

Hereditary factor IX deficiency

0.00

0.0

1.2

—

Genetic anomalies of leukocytes

0.00

0.0

2.0

—

Congenital malformations of nose

0.00

0.0

1.1

—

Immunodeficiency with short-limbed stature

0.00

0.0

1.2

—

Secondary systemic amyloidosis

0.00

0.0

1.0

—

Hypospadias

0.00

0.0

1.0

—

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

0.00

0.0

1.4

—

Melanoma in situ of scalp and neck

0.00

0.0

1.3

—

Other and unspecified degenerative diseases of nervous system

1.00

0.00

1.3

—

Schistosomiasis [bilharziasis]

0.00

0.0

1.1

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.0

—

Immunodeficiency associated with other major defects

0.00

0.0

1.6

—

Multiple myeloma

0.88

0.00

1.3

—

Benign neoplasm: Respiratory system, unspecified

0.00

0.0

1.0

—

Cleft lip

0.00

0.0

2.0

—

Other disorders of amino-acid metabolism

0.00

0.0

1.3

—

Carcinoma in situ of skin of lip

0.00

0.0

1.3

—

Traumatic amputation of part of head

0.00

0.0

1.0

—

Benign neoplasm: Scrotum

0.00

0.0

1.0

—

Other superficial mycoses

1.02

0.00

1.2

1.3

—

Cardiomyopathy due to drugs and other external agents

0.00

0.0

1.3

—

Post-traumatic hydrocephalus, unspecified

0.00

0.0

1.6

—

Oher contracture of tendon (sheath)

0.00

0.0

1.5

—

Explosion and rupture of other specified pressurized devices

0.00

0.0

1.2

—

Benign neoplasm: Epididymis

0.00

0.0

1.0

—

Benign neoplasm: Renal pelvis

0.00

0.0

1.2

—

Use of trihexyphenidyl

0.00

0.0

1.3

—

Exposure to excessive natural heat

0.00

0.0

1.7

—

Malignant neoplasm of oropharyng

0.00

0.0

1.1

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.6

—

Alport

0.00

0.0

1.6

—

Carcinoma in situ of oesophagus

0.00

0.0

1.2

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.4

—

Congenital malformation of optic disc

0.00

0.0

1.2

—

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.6

—

Spina bifida

0.00

0.0

1.6

—

Ependymoma

0.00

0.0

1.3

—

Lichenoid drug reaction

0.00

0.0

1.3

—

Other and unspecified hydrocephalus

0.94

0.00

1.6

1.3

—

Congenital malformations of lung

0.00

0.0

1.7

—

Toxic effect of corrosive substances

0.00

0.0

1.1

—

Malignant neoplasm of meninges

0.00

0.0

1.1

—

Febrile neutrophilic dermatosis [Sweet]

0.00

0.0

1.7

—

Traumatic subcutaneous emphysema

0.00

0.0

1.0

—

Enterohaemorrhagic Escherichia coli infection

0.00

0.0

1.4

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.0

1.1

—

Other and unspecified heterotropia

0.00

0.0

1.7

—

Congenital lactase deficiency

0.00

0.0

1.1

—

Turner's syndrome

0.00

0.0

1.2

—

Disorders of glycoprotein metabolism

0.00

0.0

1.7

—

Other congenital malformations of integument

0.00

0.0

1.0

—

Reduction defects of upper limb

0.00

0.0

1.1

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Unspecified organic or symptomatic mental disorder

0.00

0.0

1.3

—

Accidental poisoning by and exposure to pesticides

0.00

0.0

1.5

—

Malignant neoplasm of accessory sinuses

0.00

0.0

1.1

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.98

0.00

1.0

1.2

—

Pityriasis lichenoides et varioliformis acuta

0.00

0.0

1.2

—

Bradycardia, unspecified, drug-induced

0.00

0.0

1.1

—

Other nonautoimmune haemolytic anaemias

0.00

0.0

1.2

—

Other zoonotic bacterial diseases, not elsewhere classified

0.00

0.0

1.2

—

Traumatic secondary and recurrent haemorrhage

0.00

0.0

1.5

—

Other and unspecified syphilis

0.00

0.0

1.4

—

Traumatic amputation of hip and thigh

0.00

0.0

1.2

—

Congenital dyserythropoietic anaemia

0.00

0.0

1.0

—

Brain mixed glioma

0.00

0.0

1.4

—

Traumatic amputation of ankle and foot

0.00

0.0

1.2

—

Transepidermal elimination disorders

0.00

0.0

1.3

—

Leishmaniasis

0.00

0.0

1.4

—

Sweet's syndrome

0.00

0.0

1.7

—

Nonadministration of surgical and medical care

0.00

0.0

1.1

—

Toxic erythema

0.00

0.0

1.2

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

0.0

1.5

—

Erythema in diseases classified elsewhere

0.00

0.0

1.4

—

Frostbite with tissue necrosis

0.00

0.0

1.1

—

Benign neoplasm: Other and unspecified parts of small intestine

0.85

0.00

1.8

1.3

—

Multiple superficial injuries of ankle and foot

0.00

0.0

2.0

—

Calcium deposit in bursa

0.00

0.0

1.2

—

Epiphora

0.97

0.00

1.4

1.3

—

Poikiloderma of Civatte

0.00

0.0

1.6

—

Acne varioliformis

0.00

0.0

1.0

—

Fitting and adjustment of external prosthetic device

0.00

0.0

1.1

—

Benign neoplasm: Scrotum

0.00

0.0

1.0

—

Pemphigus erythematosus

0.00

0.0

1.2

—

Oesophagitis, drug-induced

0.00

0.0

1.0

—

Diffuse (eosinophilic) fasciitis

0.00

0.0

1.3

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

-0.00

0.0

1.1

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS